Calcium channel blocking agents.
D001552:Benzazepines / Q000494:pharmacology*; D002118:Calcium; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D006332:Cardiomegaly / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy; D004110:Diltiazem / Q000494:pharmacology* / Q000627:therapeutic use; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007473:Ion Channels; D009543:Nifedipine / Q000494:pharmacology* / Q000627:therapeutic use; D011725:Pyridines / Q000494:pharmacology*; D013599:Systole / Q000187:drug effects; D014700:Verapamil / Q000494:pharmacology* / Q000627:therapeutic use
D001552:Benzazepines; D002121:Calcium Channel Blockers; D007473:Ion Channels; D011725:Pyridines; D014700:Verapamil; D004110:Diltiazem; D009543:Nifedipine; D002118:Calcium